drugset / Trial / NCT05395104

A Study to Assess the Effect of Cefiderocol on the Pharmacokinetics (PK) of Midazolam in Healthy Participants

NCT05395104

Phase 1 Completed 14 enrolled Shionogi
NaSequentialOpen-labelTreatment

Summary

The purpose of this study is to determine the effect of repeated doses of cefiderocol on the PK of midazolam.

Timeline

Start
2022-05-24
Primary completion
2022-07-13
Completion
2022-07-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Cefiderocol Small molecule Intravenous
Subject Midazolam Small molecule Oral

Indications

No indication recorded.